RNS Number : 2125B
Chill Brands Group PLC
31 May 2023
 

 

31 May 2023

 

Chill Brands Group plc

("Chill Brands" or the "Company")

 

Total Voting Rights

 

Chill Brands Group, the international consumer packaged goods company, announces that the issued share capital of the Company at the date of this announcement comprises 287,615,305 ordinary shares of 1 pence each with one voting right per share ('Ordinary Shares').  The Company does not hold any Ordinary Shares in treasury. The total number of Ordinary Shares and voting rights in the Company is therefore 287,615,305.

 

This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

About Chill Brands Group

 

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is concerned with the development, marketing and distribution of wellness and recreational products containing natural, functional ingredients. The Company's proprietary product range is distributed by some of the most recognisable convenience retail outlets in the US and includes nicotine-free disposable vapour products that cater to the rapidly growing market for tobacco alternatives. Chill Brands also operates the chill.com e-commerce website, on which it is building a marketplace of products from third-party brands.

 

Publication on website

 

A copy of this announcement is also available on the Group's website at http://www.chillbrandsgroup.com

Media enquiries:

Chill Brands Group plc

 

contact@chillbrandsgroup.com

Allenby Capital Limited (Financial Adviser and Broker)

Nick Harriss/Nick Naylor/Lauren Wright

(Corporate Finance)
Kelly Gardiner (Equity Sales)

+44 (0) 20 3328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRWPUMCAUPWGWG